Results from the I-RUX Study published online in the British Journal of Haematology WEST HOLLYWOOD, Calif., Dec. 20, 2022 /PRNewswire/ -- ONCOtherapeutics and Dr. James Berenson published promising new data demonstrating that ruxolitinib (RUX), an oral JAK1/2 inhibitor, with only...
News Ticker
- [ February 4, 2023 ] Manager Operations Regional Laboratory Cytology/ Cytogenetic – Kaiser Permanente – North Hollywood, CA Los Angeles Biotech Jobs
- [ February 4, 2023 ] Research Lab Technician I – USC – Los Angeles, CA Los Angeles Biotech Jobs
- [ February 4, 2023 ] Research Technician – California Institute of Technology – Pasadena, CA Los Angeles Biotech Jobs
- [ February 4, 2023 ] Oncology Sales Specialist (Solid Tumor)- Orange County, CA – Janssen Biotech, Inc. – Johnson & Johnson – Irvine, CA Los Angeles Biotech Jobs
- [ February 4, 2023 ] Scientist, Flow Cytometry – NKGen Biotech – Santa Ana, CA Los Angeles Biotech Jobs
Copyright © 2021 Biotech Networks, LLC
